Pacific Biosciences Of California Debt to Equity Ratio 2009-2018 | PACB

Current and historical debt to equity ratio values for Pacific Biosciences Of California (PACB) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Pacific Biosciences Of California debt/equity for the three months ending December 31, 2018 was 0.13.
Pacific Biosciences Of California Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2018-12-31 $0.02B $0.11B 0.13
2018-09-30 $0.01B $0.13B 0.11
2018-06-30 $0.01B $0.09B 0.17
2018-03-31 $0.01B $0.10B 0.14
2017-12-31 $0.01B $0.09B 0.16
2017-09-30 $0.01B $0.10B 0.10
2017-06-30 $0.01B $0.12B 0.09
2017-03-31 $0.01B $0.07B 0.19
2016-12-31 $0.02B $0.09B 0.19
2016-09-30 $0.02B $0.10B 0.16
2016-06-30 $0.02B $0.11B 0.14
2016-03-31 $0.02B $0.09B 0.17
2015-12-31 $0.02B $0.07B 0.20
2015-09-30 $0.02B $0.04B 0.36
2015-06-30 $0.02B $0.03B 0.43
2015-03-31 $0.01B $0.04B 0.35
2014-12-31 $0.01B $0.06B 0.26
2014-09-30 $0.01B $0.05B 0.26
2014-06-30 $0.01B $0.06B 0.23
2014-03-31 $0.01B $0.08B 0.18
2013-12-31 $0.01B $0.07B 0.19
2013-09-30 $0.01B $0.08B 0.16
2013-06-30 $0.01B $0.10B 0.13
2013-03-31 $0.02B $0.11B 0.14
2012-12-31 $0.00B $0.11B 0.00
2012-09-30 $0.00B $0.13B 0.02
2012-06-30 $0.00B $0.15B 0.02
2012-03-31 $0.00B $0.17B 0.02
2011-12-31 $0.00B $0.19B 0.02
2011-09-30 $0.00B $0.21B 0.02
2011-06-30 $0.00B $0.23B 0.02
2011-03-31 $0.00B $0.25B 0.01
2010-12-31 $0.00B $0.28B 0.01
2010-09-30 $0.00B $-0.27B -0.01
2010-06-30 $0.00B $0.00B 0.00
2010-03-31 $0.00B $0.00B 0.00
2009-12-31 $0.00B $0.00B 0.00
2009-09-30 $0.00B $0.00B 0.00
2008-12-31 $0.00B $-0.10B -0.01
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.111B $0.079B
Pacific Biosciences of California, Inc. is engaged in the development, manufacture and commercialization of its single molecule, real-time, or SMRT technology-an integrated platform for genetic analysis. The SMRT technology uses the natural processing power of enzymes, combined with specially designed reagents and detection systems, to record individual biochemical events as they occur. The Company's technology platform comprises of the SMRT cells, Phospholinked nucleotides and the PacBio RS (an instrument that conducts, monitors and analyzes single molecule biochemical reactions in real time). Its product will find its application in both research institutions and commercial companies, including genome centers, government and academic institutions, genomic service providers, pharmaceutical companies and agriculture companies. Pacific Biosciences of California, Inc. is headquartered in Menlo Park, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $106.119B 23.92
Intuitive Surgical (ISRG) United States $64.916B 60.64
Edwards Lifesciences (EW) United States $39.343B 40.29
Fresenius Medical Care AG KGaA (FMS) Germany $24.388B 16.70
IDEXX Laboratories (IDXX) United States $18.775B 51.12
ABIOMED (ABMD) United States $15.300B 101.00
Teleflex (TFX) United States $13.871B 30.42
Hologic (HOLX) United States $13.817B 20.89
DexCom (DXCM) United States $13.225B 506.69
Varian Medical Systems (VAR) United States $12.404B 30.98
STERIS (STE) United Kingdom $10.430B 26.81
Masimo (MASI) United States $7.078B 44.07
Penumbra (PEN) United States $5.361B 303.31
Integra LifeSciences Holdings (IART) United States $4.828B 23.41
Globus Medical (GMED) United States $4.715B 28.62
LivaNova (LIVN) United Kingdom $4.639B 28.36
Tandem Diabetes Care (TNDM) United States $4.153B 0.00
Wright Medical Group (WMGI) Netherlands $4.065B 0.00
Cantel Medical (CMD) United States $2.808B 27.93
Integer Holdings (ITGR) United States $2.794B 22.80
Glaukos (GKOS) United States $2.717B 0.00
Inogen (INGN) United States $2.097B 41.79
AVANOS MEDICAL, INC (AVNS) United States $2.029B 22.04
OPKO Health (OPK) United States $1.545B 0.00
Nevro (NVRO) United States $1.360B 0.00
Tactile Systems Technology (TCMD) United States $1.156B 219.50
Luminex (LMNX) United States $1.096B 50.08
CryoLife (CRY) United States $1.089B 117.40
ORTHOFIX MEDICAL INC (OFIX) United States $1.083B 29.43
Accelerate Diagnostics (AXDX) United States $1.082B 0.00
Intersect ENT (XENT) United States $1.023B 0.00
Veracyte (VCYT) United States $0.906B 0.00
Natus Medical (BABY) United States $0.904B 18.84
Mesa Laboratories (MLAB) United States $0.892B 36.47
AngioDynamics (ANGO) United States $0.822B 26.67
AxoGen (AXGN) United States $0.814B 0.00
ViewRay (VRAY) United States $0.783B 0.00
OrthoPediatrics (KIDS) United States $0.688B 0.00
Quotient (QTNT) Switzerland $0.598B 0.00
Fluidigm (FLDM) United States $0.564B 0.00
TransEnterix (TRXC) United States $0.484B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.475B 50.03
Corindus Vascular Robotics (CVRS) United States $0.466B 0.00
Si-Bone (SIBN) United States $0.461B 0.00
Accuray (ARAY) United States $0.423B 0.00
GenMark Diagnostics (GNMK) United States $0.418B 0.00
Pulse Biosciences (PLSE) United States $0.390B 0.00
RTI Surgical (RTIX) United States $0.368B 53.73
Neuronetics (STIM) United States $0.316B 0.00
IRadimed (IRMD) United States $0.281B 59.51
SeaSpine Holdings (SPNE) United States $0.276B 0.00
Sientra (SIEN) United States $0.257B 0.00
Nuvectra (NVTR) United States $0.219B 0.00
CRH Medical (CRHM) Canada $0.203B 47.17
Helius Medical Technologies (HSDT) United States $0.164B 0.00
Ekso Bionics Holdings (EKSO) United States $0.161B 0.00
ConforMIS (CFMS) United States $0.145B 0.00
Biosig Technologies (BSGM) United States $0.137B 0.00
Sensus Healthcare (SRTS) United States $0.126B 0.00
Alphatec Holdings (ATEC) United States $0.118B 0.00
T2 Biosystems (TTOO) United States $0.113B 0.00
Second Sight Medical Products (EYES) United States $0.107B 0.00
SOLITON INC (SOLY) $0.107B 0.00
Vermillion (VRML) United States $0.100B 0.00
EDAP TMS (EDAP) France $0.086B 0.00
Apollo Endosurgery (APEN) United States $0.074B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.073B 0.00
Titan Medical (TMDI) Canada $0.065B 0.00
Ra Medical Systems (RMED) United States $0.049B 0.00
Electromed (ELMD) United States $0.046B 23.87
Avinger (AVGR) United States $0.044B 0.00
Xtant Medical Holdings (XTNT) United States $0.040B 0.00
OBALON THERPTCS (OBLN) United States $0.038B 0.00
Microbot Medical (MBOT) United States $0.034B 0.00
Restoration Robotics (HAIR) United States $0.032B 0.00
Viveve Medical (VIVE) United States $0.031B 0.00
PAVmed (PAVM) United States $0.028B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.026B 0.00
Lianluo Smart (LLIT) China $0.025B 0.00
Atossa Genetics (ATOS) United States $0.024B 0.00
DarioHealth (DRIO) Israel $0.023B 0.00
Bioanalytical Systems (BASI) United States $0.020B 63.33
ENDRA Life Sciences (NDRA) United States $0.019B 0.00
Dynatronics (DYNT) United States $0.017B 0.00
ReWalk Robotics (RWLK) Israel $0.017B 0.00
Presbia (LENS) Ireland $0.016B 0.00
American Shared Hospital Services (AMS) United States $0.016B 11.87
Nanovibronix (NAOV) United States $0.015B 0.00
Neovasc (NVCN) Canada $0.013B 0.00
Micron Solutions (MICR) United States $0.008B 0.00
Allied Healthcare Products (AHPI) United States $0.007B 0.00
Cesca Therapeutics (KOOL) United States $0.007B 0.00
InspireMD (NSPR) Israel $0.007B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.005B 0.00
Sunshine Heart Inc (CHFS) United States $0.002B 0.00
Check-Cap (CHEK) Israel $0.000B 0.00